Tyr0-Neurokinin A

CSCC[C@@H](C(N)=O)NC([C@H](CC(C)C)NC(CNC([C@H](C(C)C)NC([C@@H](NC([C@H](CO)NC([C@H](CC(O)=O)NC([C@H]([C@H](O)C)NC([C@H](CCCCN)NC([C@@H](NC([C@@H](N)CC1=CC=C(C=C1)O)=O)CC2=CN=CN2)=O)=O)=O)=O)=O)CC3=CC=CC=C3)=O)=O)=O)=O

[1]Gao X, et al. The study of the conformation and interaction of two tachykinin peptides in membrane mimicking systems by NMR spectroscopy and pulsed field gradient diffusion. Biopolymers. 1999 Oct 15;50 (5) :555-68. |[2]Gerhart-Hines Zachary, et al. Peptide agonists of Tacr2 for treatment of insulin resistance, diabetes and/or obesity. Patent. WO2021073742.